New Distribution agreement with Ager Agro

RNS Number : 8573G
Plant Health Care PLC
01 April 2022
 

RNS

1 April 2022

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

New Distributor Appointed for Two New Markets

 

Ager Agro SAS Selected as Distributor in Argentina and Uruguay

 

Plant Health Care® (AIM: PHC.L ), a leading provider of novel patent-protected biological products to global agriculture markets, announces plans to commence commercial sales in two new and significant markets with the appointment of Ager Agro SAS ("Ager") as a distributor of Plant Health Care's Harpin α product, ProAct®, in Argentina and Uruguay.

 

Highlights

· New agreement with Ager, which supplied products to 10 million total treated hectares of crops in Argentina in 2021

· ProAct shown to increase yield by 5% in early season soybeans exposed to drought

· Sales to start in Argentina in the third quarter of 2022

· Argentina is the world's third largest grower of soybeans (more than 16 million hectares)

· Registration for commercial sale to commence in Uruguay

 

Background

Harpin α   works by triggering the plant's own self defense systems, in a manner similar to vaccinations in humans, with crops responding with improved quality, nutrient use efficiency, tolerance to abiotic stress and ultimately, increased yield. Being a biological product, Harpin α has a very favorable human and environmental safety profile.

 

Evaluated over four crop seasons in Argentina, the application of ProAct as a soybean seed treatment resulted in measurably healthier, more robust plants and increased yield by almost 5% in early season soybeans subjected to stress from drought or heat.

 

Ager is a rapidly growing, multi-national distributor, with a particular focus on sustainably improving food quality and productivity across Argentina, Uruguay and Paraguay.  In Argentina, Ager supplied product to some 10 million total treated hectares of crops in 2021.  Today's appointment of Ager demonstrates the commercial appetite for ProAct in South America and significantly expands Plant Health Care's market access with leading partners across the region. Ager will commence sales of ProAct for soybean in Argentina during the third quarter of 2022 and is targeting 350k hectares of soybeans and 150k hectares of wheat within five years; this would generate in excess of $0.75m sales for Plant Health Care.

 

Argentina is the world's third largest producer of soybeans (after Brazil and the USA).  More than 16 million hectares were planted in 2021. Furthermore, farmers are under increasing pressure to move to more environmentally and biologically friendly products to improve the sustainability of production.

 

Chris Richards, CEO of Plant Health Care said, ‟Global sales of Harpin α grew by 55% in 2021, as more farmers recognize the value of the product. Commencing commercial sales in Argentina will materially support continued strong revenue growth.  Argentine growers are sophisticated and operate on a large scale; they are increasingly adopting more sustainable approaches. Ager has demonstrated its commitment to sustainable agriculture and its ability to commercialise biological products at scale.   ProAct makes a strong addition to their impressive portfolio. Plant Health Care and Ager Agro share a similar vision for how products like ProAct can help growers maximize their productivity in an environmentally sustainable manner and we are therefore delighted to be working alongside them."

 

Julian Etchegoyen, CEO of AGER AGRO said, "We are innovative technology providers for Latin America farmers. Our Commitment is to continue adding value in a sustainable way, convinced that the future of agriculture will have a high rate of adoption of biological products. In line with this, our strategic alliance with Plant Health Care allows us to offer in Argentina and Uruguay a valuable technology based on Harpin  protein, which generates a proven increase in crop yield of around 5%. We are very excited about this alliance and we have no doubt that ProAct will be an important player in this growing market." 

 

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, CEO

+1 919 926 1600

Arden Partners plc - Nomad & Joint Broker

 

John Llewellyn-Lloyd / Antonio Bossi

+44 (0) 20 7614 5900

Cenkos Securities plc - Joint Broker

 

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Vox Markets - Digital Investor Relations

 

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

Ager Agro SAS

 

Julian Etchegoyen

+54 9 2477 464234

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and s upply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

About Ager Agro SAS

AGER in Latin means "Agro" and refers to the company's supply of products and services focused on agricultural technology. AGER has strategic alliances with partners around Latin America, to offer integral solutions to agricultural producers with products that solve nutritional deficiencies, reduces crop stress and improves yield. Find out more at the company website: www.ager-agro.com  

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAXDFDADAEFA
UK 100

Latest directors dealings